Paper15040941
Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
Fattom AI and 4 others. Vaccine, 2004. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Papers, record 15040941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15040941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Staphylococcal Infections | Major topic |
| Staphylococcal Vaccines | Major topic |
| Animals | |
| Clinical Trials, Phase III as Topic | |
| Humans | |
| Vaccines, Conjugate |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41663438 | AntiPan: a genome-informed in silico pipeline for advancing subunit vaccine discovery against Staphylococcus aureus. | Sci Rep | 2026 | https://conductscience.org/library/papers/41663438 | PubMed |
| 41423820 | Chemical Synthesis of Pseudomonas aeruginosa, Staphylococcus aureus, and Acinetobacter baumannii Capsular Polysaccharide Fragments as Leads for Cross-Protection. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/41423820 | PubMed |
| 40871236 | Staphylococcus aureus in Foodborne Diseases and Alternative Intervention Strategies to Overcome Antibiotic Resistance by Using Natural Antimicrobials. | Microorganisms | 2025 | https://conductscience.org/library/papers/40871236 | PubMed |
| 40823959 | Synthesis, Conformal Analysis, and Antibody Binding of Staphylococcus aureus Capsular Polysaccharide Type 5 Oligosaccharides. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40823959 | PubMed |
| 39922982 | Protection of Mice Vaccinated with a New B Cell and T Cell Epitopes Cocktail from Staphylococcus aureus Challenge in Skin Infection Model. | Curr Microbiol | 2025 | https://conductscience.org/library/papers/39922982 | PubMed |
| 39792791 | Long, Synthetic Staphylococcus aureus Type 8 Capsular Oligosaccharides Reveal Structural Epitopes for Effective Immune Recognition. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/39792791 | PubMed |
| 39591106 | Electron-Beam-Killed Staphylococcus Vaccine Reduced Lameness in Broiler Chickens. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39591106 | PubMed |
| 38573919 | A practical guide for the husbandry of cave and surface invertebrates as the first step in establishing new model organisms. | PLoS One | 2024 | https://conductscience.org/library/papers/38573919 | PubMed |
| 38001039 | Use of Transcriptional Signatures to Differentiate Pathogen-Specific and Treatment-Specific Host Responses in Patients With Bacterial Bloodstream Infections. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38001039 | PubMed |
| 37261327 | Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37261327 | PubMed |
| 37125490 | Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37125490 | PubMed |
| 36986298 | Designing a Next-Generation Multiepitope-Based Vaccine against Staphylococcus aureus Using Reverse Vaccinology Approaches. | Pathogens | 2023 | https://conductscience.org/library/papers/36986298 | PubMed |
| 35608633 | Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. | Chem Rev | 2022 | https://conductscience.org/library/papers/35608633 | PubMed |
| 34122448 | Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia. | Front Immunol | 2021 | https://conductscience.org/library/papers/34122448 | PubMed |
| 34088508 | A protein A based Staphylococcus aureus vaccine with improved safety. | Vaccine | 2021 | https://conductscience.org/library/papers/34088508 | PubMed |
| 34069873 | Staphylococcal Infections: Host and Pathogenic Factors. | Microorganisms | 2021 | https://conductscience.org/library/papers/34069873 | PubMed |
| 33562054 | Immune-Based Anti-Staphylococcal Therapeutic Approaches. | Microorganisms | 2021 | https://conductscience.org/library/papers/33562054 | PubMed |
| 33291260 | T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection. | Microorganisms | 2020 | https://conductscience.org/library/papers/33291260 | PubMed |
| 32539814 | Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development. | BMC Res Notes | 2020 | https://conductscience.org/library/papers/32539814 | PubMed |
| 31133995 | Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31133995 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15040941
GET https://conductscience.org/api/papers/v1/15040941/cited_by?page=2